Powered by

Powered by Portfolio Grader

Sarepta Therapeutics (SRPT)

116.64 2.09 (1.76%) 18:39 EDT
SRPT Stock Quote Delayed 15 Minutes

  • SRPT Stock Chart

  • Historical SRPT Prices

  
Dividend & Yield:       N/A (N/A)
P/E:       -39.67
Market Cap:       7.64B
EPS:       -2.94
Volume:       2.39M
Day's Range:       116.26 - 120.17
52wk Range:       74.51 - 176.50
Quotes delayed at least 20 mins.
Historical Data for SRPT
Month:  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Year:  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Range:  1 Month 3 Month 1 Year
Date Open High Low Volume Close Change %
04/18/19 119.01 120.17 116.26 2,391,500 116.64 -2.09   -1.76%
04/17/19 122.12 124.35 117.63 1,605,247 118.73 -2.86   -2.35%
04/16/19 120.13 125.13 120.00 909,645 121.59 1.82   1.52%
04/15/19 117.63 120.15 116.84 1,023,933 119.77 2.28   1.94%
04/12/19 121.81 122.76 117.48 1,178,900 117.49 -3.13   -2.59%
04/11/19 126.90 127.00 120.27 866,253 120.62 -5.99   -4.73%
04/10/19 124.50 127.34 123.53 607,195 126.61 2.60   2.10%
04/09/19 123.17 126.25 122.69 571,607 124.01 0.07   0.06%
04/08/19 124.69 124.93 121.64 656,595 123.94 -0.94   -0.75%
04/05/19 121.27 125.50 121.27 1,096,700 124.88 3.85   3.18%
04/04/19 122.74 123.27 119.27 925,097 121.03 -1.65   -1.34%
04/03/19 122.81 124.41 121.65 729,750 122.68 -0.02   -0.02%
04/02/19 118.00 124.00 117.19 1,349,035 122.70 4.58   3.88%
04/01/19 120.18 121.03 116.80 1,139,191 118.12 -1.07   -0.90%
03/29/19 119.16 120.00 117.28 1,581,400 119.19 0.51   0.43%
03/28/19 119.63 120.05 116.20 1,325,266 118.68 2.10   1.80%
03/27/19 121.62 122.33 115.65 1,414,679 116.58 -5.42   -4.44%
03/26/19 119.65 122.75 118.50 1,490,360 122.00 3.08   2.59%
03/25/19 126.02 126.36 113.51 2,731,927 118.92 -3.34   -2.73%
03/22/19 125.61 127.35 122.25 1,216,600 122.26 -4.40   -3.47%
03/21/19 127.50 131.99 124.86 1,894,719 126.66 2.81   2.27%
03/20/19 125.85 126.17 121.61 1,349,053 123.85 -2.62   -2.07%
03/19/19 126.95 127.13 124.70 968,534 126.47 -0.35   -0.28%
03/18/19 128.12 130.11 125.30 1,206,604 126.82 -1.54   -1.20%
03/15/19 129.48 130.96 127.02 1,158,900 128.36 -1.05   -0.81%
03/14/19 132.60 133.62 129.30 1,205,562 129.41 -3.19   -2.41%
03/13/19 134.93 135.52 131.52 755,557 132.60 -1.42   -1.06%
03/12/19 134.38 135.83 132.72 822,912 134.02 -0.37   -0.28%
03/11/19 130.63 135.20 130.00 1,233,952 134.39 3.59   2.74%
03/08/19 130.88 132.24 128.50 1,354,700 130.80 -3.13   -2.34%
03/07/19 134.01 136.35 129.57 2,179,237 133.93 1.68   1.27%
03/06/19 142.50 142.50 131.55 6,675,286 132.25 -16.54   -11.12%
03/05/19 145.59 150.90 144.15 1,489,254 148.79 3.31   2.28%
03/04/19 148.44 148.44 143.10 1,457,710 145.48 -1.21   -0.82%
03/01/19 144.97 148.34 144.46 1,259,700 146.69 2.45   1.70%
02/28/19 148.92 148.92 143.00 2,324,468 144.24 -7.44   -4.91%
02/27/19 151.99 155.23 145.25 4,380,165 151.68 11.64   8.31%
02/26/19 143.00 143.24 138.15 964,523 140.04 -3.59   -2.50%
02/25/19 143.93 149.70 142.38 2,010,263 143.63 3.65   2.61%
02/22/19 137.50 140.31 135.49 776,700 139.98 3.44   2.52%
02/21/19 143.58 145.46 134.29 963,794 136.54 -4.03   -2.87%
02/20/19 140.65 142.38 137.52 695,294 140.57 0.31   0.22%
02/19/19 137.60 140.73 137.60 608,972 140.26 1.81   1.31%
02/15/19 134.90 139.24 134.00 877,600 138.45 3.57   2.65%
02/14/19 135.00 135.95 132.53 664,623 134.88 0.14   0.10%
02/13/19 133.59 135.72 131.13 998,445 134.74 1.83   1.38%
02/12/19 127.90 133.26 127.90 880,340 132.91 5.91   4.65%
02/11/19 130.00 132.79 126.95 1,225,401 127.00 -0.87   -0.68%
02/08/19 135.92 136.47 126.14 2,149,700 127.87 -9.57   -6.96%
02/07/19 144.30 147.55 134.13 2,353,134 137.44 -4.05   -2.86%
02/06/19 141.84 142.31 139.06 1,093,212 141.49 -0.22   -0.16%
02/05/19 141.85 144.99 141.09 1,143,882 141.71 0.11   0.08%
Download Data To Spreadsheet
Sarepta Therapeutics (SRPT) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Sarepta Therapeutics Stock Analysis

Rating: Buy

Total Grade: B

Analysis Breakdown

SRPT Stock Grade: B
Fundamental Grade: D
Quantitative Grade: B
SRPT Earnings
Earnings Growth: C
Earnings Momentum: C
Earnings Surprises: F
Analyst Earnings Revisions: F
SRPT Financial Information
Sales Growth: A
Operating Margin Growth: C
Cash Flow: F
Return on Equity: F

Sarepta Therapeutics Stock: Weekly View

This Week: B
Last Week: B
Two Weeks Ago: B
Get Full Report